Induction of CD4+ regulatory T cells by 12-O-tetradecanoylphorbol 13-acetate in mice. Part 1: The strain difference in this induction

International Immunopharmacology

Volumn 1, Issue 6, 2001, Pages 1153-1163

  Negoro, Takaharu ^a   Iinuma, Fumio ^b   Tobe, Takashi ^a   Watanabe, Mitsuo ^b  

^a SHOWA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

DIF; DTH; Immunomodulation; TPA

Indexed keywords

CD4 ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CROSS REACTION; DELAYED HYPERSENSITIVITY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; STRAIN DIFFERENCE; T LYMPHOCYTE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIGENS, CD4; ANTIGENS, SURFACE; DOWN-REGULATION; FEMALE; HYBRIDOMAS; HYPERSENSITIVITY, DELAYED; INDICATORS AND REAGENTS; MALE; MICE; MICE, INBRED STRAINS; SPECIES SPECIFICITY; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0035025763     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00049-2     Document Type: Article

References (36)

1. Dean H., Luster M.I., Ward E.C., Lauer L.D. Immunosuppression by the tumor promoting phorbol diester TPA: a possible mechanism in carcinogenesis. Mullein P.W. Immnotoxicology. 1984;47-58 Springer, Berlin.
2. Touraine F.L., Hadden J.W., Touraine F., Estensen R., Good R.A. Phorbol myristate acetate. J. Exp. Med. 145:1977;460-465.
3. Abb J., Bayliss G.J., Deinhardt F. Lymphocyte activation by the tumor-promoting agent 12-O-tetradecanoylphorbol 13-acetate (TPA). J. Immunol. 122:1979;1639-1644.
4. Yamashita U. Requirement of Ia positive accessory cells for T-cell stimulation with 12-tetradecanoylphorbol 13-acetate. Cell. Immunol. 75:1983;56-63.
5. Mizel S.B., Rosenstreich D.L., Oppenheim J.J. Phorbol myristate acetate stimulates LAF production by the macrophage cell line P388D. Cell. Immunol. 40:1978;230-235.
6. Farrar J.J., Fullea-Farrar W.L., Simon P.L., Hilfiker M.L., Stadler B.M., Farrar W.L. Thymoma production of T cell growth factor (interleukin 2). J. Immunol. 125:1980;2555-2558.
7. Andreotti P.E. Phorbol ester tumor promotor modulation of allo-antigen-specific T lymphocyte responses. J. Immunol. 129:1982;91-96.
8. Fredrickson G.G., Bennett M. Suppression of the cytotoxic responses of mouse lymphocytes to syngeneic tumor cells by tumor promoting phorbol ester. Cancer Res. 42:1982;3601-3606.
9. Tabara M., Watanabe M. Suppression of footpad reaction in mice by 12-tetradecanoylphorbol 13-acetate and 7,12-dimethylbenz[a]anthracene. Jpn. J. Exp. Med. 58:1988;67-72.
10. Tabara M., Watanabe M. Mechanism of suppression of footpad reaction in mice by 12-tetradecanoylphorbol 13-acetate and 7,12-dimethylbenz[a]anthracene. Jpn. J. Exp. Med. 60:1990;5-11.
11. + suppressor T cells by treatment with DMBA and TPA in vitro. Cell. Immunol. 138:1991;437-444.
12. + suppressor-inducer T cells. Cell. Immunol. 167:1996;216-223.
13. Fong T.A.T., Mosmann T.R. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J. Immunol. 143:1989;2887-2893.
14. Gautam S.C., Chikkala N.F., Hamilton T.A. Anti-inflammatory action of IL-4: negative regulation of contact sensitivity to trinitrochlorobenzene. J. Immunol. 148:1992;1411-1415.
15. Mihara M., Ikuta M., Koishihara Y., Ohsugi Y. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis. Eur. J. Immunol. 21:1991;2327-2331.
16. Ferguson T.A., Dube P., Griffith T.S. Regulation of contact hypersensitivity by interleukin 10. J. Exp. Med. 179:1994;1597-1604.
17. Berg D.J., Leach M.W., Kuhn R., Rajewsky K., Muller W., Davidson N.J.et al. Interleukin 10 but not Interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:1995;99-108.
18. + suppressor T cells completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J. Autoimmun. 9:1996;331-339.
19. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
20. Hisatsune T., Ametani A., Nishijima K., Enomoto A., Kaminogawa S. Strong influence of the processing of the antigen on negative effects on T cell activation by regions outside the determinant area of bovine alpha s1-casein. Biosci. Biotech. Biochem. 56:1992;1616-1618.
21. Mosmann T.R., Schumacher J.H., Fiorentino D.F., Leverah J., Moore K.W., Bond M.W. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J. Immunol. 145:1990;2938-2945.
22. Littlefield J.W. Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science. 145:1964;709-710.
23. Plant J., Glynn A.A. Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice. Nature. 248:1974;345-347.
24. Snippe H., Johannesen L., Lizzio E., Merchant B. Variable expression of delayed hypersensitivity in different mouse strains using dimethyl dioctadecyl ammonium bromide as an adjvant. Immunology. 39:1980;399-405.
25. Alexander J., Curtis J. Development of delayed hypersensitivity responses in Mycobacterium lepraemurium infections in resistant and susceptible strains of mice. Immunology. 36:1979;563-567.
26. Mitsuoka A., Teramatsu T., Baba M., Morikawa S., Yasuhira K. Delayed hypersensitivity in mice induced by intravenous sensitization with sheep erythrocytes: evidence for tuberculin type delayed hypersensitivity of the reaction. Immunology. 34:1978;363-370.
27. Sado T., Kamisaku H., Kubo E. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow. J. Immunol. 134:1985;704-710.
28. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:1989;2081-2095.
29. Powrie F., Menon S., Coffman R.M. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:1993;2223-2229.
30. Rivas J., Ullrich S.E. Systemic suppression of delayed-type hypersensitivity by supernatants from uv-irradiated keratinocytes. J. Immunol. 149:1992;3865-3871.
31. Salerno A., Dieli F., Sireci G., Bellavia A., Asherson G.L. Interleukin-4 is a critical cytokine in contact sensitivity. Immunology. 84:1995;404-409.
32. Ferreri N.R., Millet I., Paliwal V., Herzog W., Solomon D., Ramabhdran R.et al. Induction of macrophage TNF-alpha, IL-1, IL-6 and PGE2 production by DTH-initiating factors. Cellular Immunol. 137:1991;389-405.
33. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
34. Rivas J.M., Ullrich S.E. The role of IL-4, IL-10 and TNF-alpha in the immune suppression induced by ultraviolet radiation. J. Leukoc. Biol. 56:1994;769-775.
35. Ferreri N.R., Herzog W.R., Askenase P.W. Inhibition of IL-2-dependent proliferation by a prostaglandin-dependent suppressor factor. J. Immunol. 150:1993;2102-2111.
36. Lu P., Sharom F.J. Gangliosides are potent immunosuppressors of IL-2-mediated T-cell proliferation in a low protein environment. Immunology. 86:1995;356-363.